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Abstract
Background: Intrahepatic biliary mucinous cystic neoplasms are rare hepatic tumors and account for less than 5%
of intrahepatic cystic lesions. Accurate preoperative diagnosis is difficult and the outcome differs among various
treatment modalities.The aim of this study is to investigate the clinico-radiological characteristics of intrahepatic
biliary mucinous cystic neoplasms and to establish eligible diagnostic and treatment suggestions.
Methods: Nineteen patients with intrahepatic biliary cystadenomas and two patients with biliary
cystadenocarcinomas were retrospectively reviewed. Their clinico-radiological variables and survival outcome were
analyzed.
Results: Of the 19 patients with biliary cystadenoma, 16 (84.2 %) were female. 11 (57.9 %) patients had symptoms
before operation with the most common presenting symptom being abdominal pain. Among the patients with
available data, serum and cystic fluid CA 19–9 levels were invariably elevated and the CA 19–9 level in the cystic
fluid was significantly higher than that in the serum. Loculations (84.2 %) and septations (63.2 %) were the most
common radiologic findings. For treatment, 11 (57.9 %) patients received radical resection by either enucleation or
hepatic resection, while the remaining 8 (42.1 %) patients underwent only fenestration of liver cysts. Radical
resection provided a significantly better clinical outcome than fenestration in terms of tumor recurrence (p = 0.018).
The only two male patients with biliary cystadenocarcinoma received radical hepatic resection and achieved a
disease-free survival of 16.5 months and 33 months, respectively.
Conclusion: Intrahepatic biliary mucinous cystic neoplasms are rare and preoperative diagnosis is difficult. Internal
septations and loculations on radiologic examinations should raise some suspicion of this diagnosis. Complete
tumor excision is the standard treatment that may provide patients with better long term results after the
operation.
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Background
Cystic lesions of the liver are being discovered more fre-
quently nowadays owing to advances in abdominal im-
aging including sonography and computed tomography.
They are mostly benign and asymptomatic [1]. The dif-
ferential diagnoses are diverse and treatment modalities
differ. Intrahepatic biliary mucinous cystic neoplasms,
traditionally categorized as either biliary cystadenomas
or biliary cystadenocarcinomas, have been reclassified
into mucinous cystic neoplasms with low-, intermediate,
high-grade intraepithelial neoplasia, or an associated in-
vasive carcinoma [2]. These lesions account for less than
5 % of hepatic cystic lesions [3]. Since the first discovery
in 1887 [4], many studies have been published in an ef-
fort to provide suggestions regarding the diagnosis and
treatment for intrahepatic biliary mucinous cystic neo-
plasms. However, most of these articles have been case
reports or small case series, rendering their suggestions
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less convincing. Regrettably, an accurate preoperative
diagnosis for intrahepatic biliary mucinous cystic neo-
plasms remains difficult and controversy exists in
regards to the appropriate treatment and follow-up.
Therefore, the purpose of this study is to share the
experience in our institute and to investigate the clinico-
radiological characteristics of intrahepatic biliary mucin-
ous cystic neoplasms. Suggestions on the subject of
preoperative diagnosis and treatment strategy will also
be provided.
Materials and methods
From December 1986 to December 2012, patients with
intrahepatic biliary mucinous cystic neoplasms who
underwent surgery at Chang Gung Memorial Hospital,
Linkou, were retrospectively reviewed. Preoperative
contrast-enhanced computed tomography (CE-CT) or
contrast-enhanced magnetic resonance image (MRI) of
liver was routinely performed and interpreted by radiol-
ogists experienced in the hepatobiliary system. The radi-
ologists focused their image interpretation on the
presence of the following features: internal septation,
loculation, cystic wall enhancement, cystic wall thicken-
ing and/or mural nodules, and biliary dilatation, as dem-
onstrated in Fig. 1.
The patients received surgical interventions after ex-
tensive evaluations and the operations were performed
exclusively by hepatobiliary surgeons in our department.
The operative methods could be classified into either
radical resection or liver-preserving surgery. Radical re-
section included tumor enucleation and anatomical hep-
atic resection, while liver-preserving surgery included
cystic fenestration, marsupialization, and partial tumor
excision. The methods of operations were left to the sur-
geons’ discretion. Intra-operative findings were recorded
accordingly; however, no intraoperative frozen section
examinations were performed.
The specimens were examined and the diagnosis of
intrahepatic biliary cystadenoma and cystadenocarci-
noma was made by histopathologists expertised in the
hepatobiliary system. Postoperatively, the patients had
regular follow-up visits every 3 months for two consecu-
tive years and then every 6 months thereafter. Serum
tumor markers and imaging studies such as ultrasonog-
raphy, CT, or MRI were conducted periodically during
follow-up visits. Postoperative symptom resolution,
tumor recurrence, additional interventions, and survival
outcome were recorded.
The statistical analysis was performed with SPSS 17.0
for Windows (SPSS Inc., Chicago, IL, USA). Fisher’s
exact test or Pearson’s χ2 test was used to analyze cat-
egorical data. Student’s t test was used to analyze con-
tinuous variables. Disease-free survival (DFS) was
calculated from the date of operation to the date of first
documented radiological recurrence. Overall survival
(OS) was defined by the time elapsing from the date of
diagnosis to either the date of death or the date of the
last contact. Statistical significance was defined as p
values < 0.05.
Results
During the study period, a total of 21 patients with
intrahepatic biliary mucinous cystic neoplasms who
underwent surgery at our hospital were included and ex-
amined. Among them, nineteen patients had biliary
cystadenoma and two patients had biliary cystadenocar-
cinoma. Their respective clinico-radio-pathological find-
ings and surgical results are listed below:
Cystadenoma
The mean age upon diagnosis was 57 and 16 patients
(84.2 %) were female. Female patients tended to be
younger than male patients upon diagnosis. (54.7 vs.
69.3 year-old, p = 0.017). The demographic data and pre-
operative serum/cystic fluid tumor marker levels are
shown in Table 1.
As for clinical presentation, 11 patients (57.9 %) were
symptomatic, with a duration of these symptoms ranging
from 10 days to 2 years. Of these, 54.5 % approached for
hospital care within 1 month of onset of the symptoms.
The frequency of presenting symptoms are summarized
in Table 2.
Radiologic examinations revealed that 14 patients
(87.5 %) had loculations, demonstrating such being the
most common radiologic finding among the patients
with intrahepatic biliary cystadenoma. The second most
common finding was internal septations (56.3 %). Cystic
wall enhancement, cystic wall thickening / mural nod-
ules, and biliary dilatation were also common features.
Every patient had at least one characteristic finding
mentioned above. The imaging studies of three patients
were inaccessible due to prolonged history and were
therefore not included in our analysis.
As for preoperative diagnosis, only 6 patients (31.58 %)
received preoperative percutaneous aspiration cytology
or biopsy, of which showed negative results for malig-
nancy without specific diagnosis. The definitive diagnosis
still depended on the pathological examination of excised
specimen (Table 3). All 19 patients received surgical
intervention for their respective intrahepatic biliary
cystadenoma. The mean tumor size was 8.5 cm in diam-
eter, with the size ranging from 2.5 cm to 21.0 cm at the
largest dimension. The radiologic findings and surgical
indications are summarized in Table 2.
As for operative methods, eleven patients (57.9 %)
received radical resections, and 8 patients (42.1 %) re-
ceived liver-preserving surgery. During their regular
postoperative follow-up visits, no tumor recurrence
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Fig. 1 Contrast-enhanced computed tomography (CE-CT) of patients with intrahepatic biliary cystadenomas. a and b, internal septation: cystic lesion
was divided by one or more septa. c and d, loculation: the presence of small spaces or cavities within the main cystic lesion. e and f, cystic wall
enhancement: the enhancement of cystic wall after contrast administration. g and h, wall thickening and/or mural nodules: the presence of cystic wall
nodules or focally thickened cystic wall. I and J, biliary dilatation: the presence of dilated intrahepatic ducts due to intrahepatic cystic lesion
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occurred in patient who received radical resections;
however, 5 out of 8 patients who received liver-
preserving surgery(62.5 %) had tumor recurrence (p =
0.005). The median follow-up time in radical resection
group was 51.3 months and the median disease-free
survival (DFS) in liver-preserving surgery group was
3.7 months. The other 3 patients in the group of liver-
preserving surgery were lost in follow-up. Among pa-
tients with postoperative tumor recurrence, 3 patients
(60 %) received further surgical interventions, namely
liver resections in 2 and cystic fenestration in 1. The first
patient who received liver resection remained disease-
and symptom-free at last follow-up. The second patient
who received liver resection during her second operation
had positive resection margins on the specimen and suf-
fered from another recurrence at resection margin two
months after the second operation. The only patient
who had re-fenestration for his recurrence was agonized
by persistent recurrent disease and right upper quadrant
abdominal pain after the second operation. Of the other
two patients with postoperative tumor recurrence, one
developed recurrence 4.17 months after the operation
and remained symptomatic throughout the follow-up,
and the other had persistent disease and died from
massive upper gastrointestinal bleeding 32 days after the
operation. Fig 2 demonstrates postoperative recurrence
after laparoscopic cystic fenestration. Table 4 summa-
rizes the operative methods and surgical outcome of pa-
tients with intrahepatic biliary cystadenoma.
Table 1 The demographic data of patients with intrahepatic biliary cystadenoma (n = 19)
Variables (%) Variables (%)
Age(yr) ALT(U/L)
≦60 12 (63.2) ≦36 3 (15.8)
>60 7 (36.8) >36 7 (84.2)
Gender Child-Pugh Classification
Male 3 (15.8) A 17 (89.5)
Female 16 (84.2) B 2 (10.5)
Cigarette Smoking Serum AFP (ng/mL)a
Yes 3 (15.8) >15 0 (0)
No 16 (84.2) Mean ± SD 3.78 ± 1.37
Alcohol Serum CEA (ng/mL)a
Yes 3 (15.8) >5 1 (10.0)
No 16 (84.2) Mean ± SD 19.03 ± 49.87
HBV Serum CA 19–9 (U/mL)a
Positive 3 (15.8) >37 6 (100.0)
Negative 16 (84.2) Mean ± SD 444.81 ± 480.45
HCV Serum CA 125 (U/mL)a
Positive 0 (0) >35 2 (50.0)
Negative 19 (100) Mean ± SD 516.73 ± 947.25
Total bilirubin(mg/dl) Cystic CEA (ng/mL)a,b 108.07 ± 139.47
≦1.3 18 (94.7) Cystic CA 19–9 (U/mL)a,b 1033140.54 ± 1376297.74
>1.3 1 (5.3) Cystic CA 125 (U/mL)a,b 1051.26 ± 1269.11
a only patients with available data were analyzed
b expressed as mean ± SD
Table 2 The presenting symptoms, radiologic findings, and




(%) Radiologic findings (%)
Asymptomatic 8 (42.1) Septation 9 (56.3)
Symptomatic 11(57.9) Loculation 14 (87.5)
Abdominal pain 8 (72.7) Wall enhancement 4 (25.0)
Abdominal mass 1 (9.1) Wall thickening / mural
nodules
4 (25.0)
Abdominal distension 1 (9.1) Biliary dilatation 4 (25.0)
Fever 2 (18.2) Surgical indications (%)
Jaundice 1 (9.1) Symptomatic relief 7 (36.8)
Dyspnea 1 (9.1) Increased size of lesion 2 (10.6)
Diarrhea 1 (9.1) Suspected neoplasm on
radiologic examination
10 (52.6)
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Cystadenocarcinoma
The first patient with intrahepatic biliary cystadenocarci-
noma was a 73 year-old male who presented with epi-
gastric pain for weeks on a background history of
chronic hepatitis B carrier. Physical and laboratory ex-
aminations were unremarkable. His serum CA 19–9
level was 111.9 U/mL. The preoperative contrast-
enhanced CT showed a loculated, infiltrative and sep-
tated cystic mass with solid component and wall en-
hancement at segment 4 and 5. Malignancy was
suspected and percutaneous biopsy showed cystic mu-
cinous neoplasm. Segmental hepatectomy (S4 and S5),
cholecystectomy and partial omentectomy were per-
formed to remove the tumor en bloc. The final path-
ology reported an 8.5 cm intrahepatic biliary
cystadenocarcinoma with a sclerotic stroma. Postopera-
tive recovery was uneventful. Nevertheless, the patient
developed intrahepatic recurrence and pulmonary me-
tastasis 16.5 months postoperatively and obtained an
overall survival (OS) of only 23.2 months.
The second patient was a 62 year-old male who pre-
sented with a two-week history of abdominal pain, left
upper quadrant in location and dull in character, in
addition to abdominal distension on a background his-
tory ofautosomal dominant polycystic kidney and liver
disease. He was also an HBV carrier. Physical examin-
ation revealed hepatosplenomegaly and left upper ab-
dominal tenderness. His serum tumor markers were
normal. Contrast-enhanced dynamic CT showed, in
addition to multiple various-sized liver cysts, a large
Table 3 Summary of preoperative cytological and postoperative pathological diagnosis
Case No./Age/
Gender
Preoperative FNACa findings Preoperative FNACa
diagnosis
Postoperative pathological diagnosis
No.2/39/Female N.A. Negative for malignancy Biliary cystadenoma
No.9/49/Female Fibrous tissue with scattered smooth muscle
bundlesb
Negative for malignancyb Biliary cystadenoma with leiomyomatous
mural nodules
No.10/65/Female Columnar/cuboidal cells with eccentric nuclei Atypia Mucinous cystadenoma
No.11/32/Female Lymphocytes and histiocytes Negative for malignancy Mucinous cystadenoma
No.12/49/Female Lymphocytes and histiocytes Negative for malignancy Mucinous cystadenoma
No.19/69/Male Lymphocytes Negative for malignancy Mucinous cystadenoma
No.20/73/Malec Cystic spaces lined by mucinous cuboidal or
columnar epithelium with papillary infoldingsb
Cystic mucinous neoplasmb Biliary cystadenocarcinoma
No.21/62/Malec Complex glandular structures floating in mucin
poolsb
Mucinous carcinoma or mucinous
cystadenocarcinoma or IPMNd b
Biliary cystadenocarcinoma
afine needle aspiration cytology
bcore needle biopsy
cbiliary cystadenocarcinoma
dintraductal papillary mucinous neoplasm
Fig. 2 Postoperative recurrence after liver-preserving surgery. A
38 year-old female received laparoscopic cystic fenestration for intra-
hepatic biliary cystadenoma. Four months after the operation, tumor
recurrence was documented by CT. The high density objects beside
the cystic tumor were hemoclips used to secure blood vessels
Table 4 The operative method and surgical outcome of
patients with intrahepatic biliary cystadenoma
Operative method (%) Post-operative
tumor recurrence
(%) P-value







Right lobe 5 (29.4)
Left lobe 10 (58.8)
Bilateral lobes 2 (11.8)
*Radical resection included enucleation and anatomical hepatic resection
**Liver-preserving surgery included cystic fenestration, marsupialization, and
partial tumor excision
Lee et al. BMC Gastroenterology  (2015) 15:67 Page 5 of 9
(14 × 9.5 cm) cystic mass at left lateral sector of liver.
The cystic tumor had diffuse mural soft tissue and fine
tumor vessels (Fig. 3). Preoperative biopsy included mu-
cinous carcinoma, mucinous cystadenocarcinoma, and
IPMN into differentials. Gastric and diaphragmatic inva-
sion was noted intraoperatively and left lateral segmen-
tectomy, wedge excision of gastric tumor, and partial
diaphragm excision was performed to obtain an R0 re-
section. Pathologic interpretation reported a 16 cm
intrahepatic biliary cystadenocarcinoma with metastatic
carcinoma in the gastric wall. Recovery was smooth and
no evidence of recurrence was found during follow-up
examinations. He was still well at last follow-up visit
33 months postoperatively.
Although only two malignant cases were reported
herein, statistical analysis was still conducted to compare
the major clinical features between biliary cystadenoma
and cystadenocarcinoma. In contrast to biliary cystade-
noma, biliary cystadenocarcinoma had a male predomin-
ance and occurred at an older age (Table 5).
Discussion
The differential diagnoses of hepatic cystic lesions
include simple cysts, parasitic cysts, mucinous cystic
Fig. 3 Contrast-enhanced triphasic liver CT of patient with intrahepatic biliary cystadenocarcinoma. The large (14 × 9.5 cm) cystic tumor
occupying left lateral liver sector had diffuse mural soft tissue and fine tumor vessels. Faint arterial blushes with whirling appearance were also
noted within the tumor and they faded throughout the dynamic study. Multiple liver cysts of various sizes were also found at the right liver lobe.
a and b: arterial phase; c: portal venous phase; d: delayed venous phase
Table 5 Comparison of clinical characteristics between biliary
cystadenoma and biliary cystadenocarcinoma
Variables Cystadenoma Cystadenocarcinoma P value
Gender
Male 3 (15.8 %) 2 (100 %) 0.008
Female 16 (84.2 %) 0 (0 %)
Age (yr)
≦60 12 (63.2) 0 (0 %) 0.086
>60 7 (36.8) 2 (100 %)
Size (cm)
≦5.0 5 (33.3 %) 0 (0 %) 0.331
>5.0 10 (66.7 %) 2 (100 %)
Serum CEA (ng/mL)a
Mean ± SEb 19.03 ± 16.62 2.25 ± 0.85 0.544
Serum CA 19–9 (U/mL)a
Mean ± SEb 444.81 ± 196.14 72.61 ± 39.29 0.699
aonly patients with available data were analyzed
bstandard error of mean
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neoplasms, congenital cystic dilatation, degenerated
metastatic tumors, mucin producing metastatic tumors,
cystic hemangioma, lymphangioma, hepatic foregut cyst,
and mesenchymal hamartoma and teratoma [5–7]. Mu-
cinous cystic neoplasms including intrahepatic biliary
cystadenoma and cystadenocarcinoma, account for ap-
proximately 5 % of hepatic cystic lesions [3]. They are
being discovered more frequently due to advances in ab-
dominal imaging modalities and improved awareness of
this disease entity. Although benign, intrahepatic biliary
cystadenomas have the potential for malignant trans-
formation and the prognosis of intrahepatic biliary cysta-
denocarcinomas is poor [8, 9].
The World Health Organization (WHO) in 2010 had re-
categorized biliary cystadenoma into mucinous cystic neo-
plasms with low-, intermediate, or high-grade intraepithelial
neoplasia and biliary cystadenocarcinoma into mucinous
cystic neoplasms with an associated invasive carcinoma [2].
However, most authors in the recent literature continue
using cystadenoma/cystadenocarcinoma to describe this
rare disease. For the convenience of further literature re-
view, we adopt the terms cystadenoma/cystadenocarcinoma
in the current study. Readers should be aware that these
terms should be avoided in the future.
The cause of intrahepatic biliary cystadenoma remains
unknown. The almost exclusive female predominance of
biliary cystadenoma (>85 %) suggests a strong hormonal
influence [10]. Our study, in which 84.2 % of the biliary
cystadenoma patients are female, corresponds to this
published result. The mean age of diagnosis in our study
is 57, which is similar to most of other series [11, 12].
This feminine hormonal influence might explain the
older age on diagnosis in male population (69.3 year-old
in male and 54.7 year-old in female patients, respectively),
of whom masculine hormone decreases with aging.
Intrahepatic biliary cystadenomas are rare. Few large
series have been reported in the literature [1, 6, 12–18].
Our study is by far one of the largest series in the Eng-
lish literature. The clinical presentations of intrahepatic
biliary cystadenomas could vary widely, as evidenced
from the literature [1, 12, 16, 17]. In contrast to the pre-
vious series, in which most patients were symptomatic
before operation, only 11 patients (57.9 %) were symp-
tomatic upon presentation in the current study and 8
patients (42.1 %) were found incidentally. The most
common presenting symptom was abdominal pain
whereas fever, abdominal mass/distension, jaundice, dys-
pnea and diarrhea were the less common symptoms.
The nonspecific nature of these symptoms rendered
clinical diagnosis difficult and laboratory/radiologic ex-
aminations imperative. Numerous efforts were taken in
the past to develop a sensitive and specific diagnostic
modality for intrahepatic biliary cystadenoma. Koffron
A. et al. suggested that cystic fluid analysis could be used
to differentiate intrahepatic biliary cystadenomas from
simple cysts, of which cystic fluid CEA and CA19-9 were
usually normal [16]. Intrahepatic biliary cystadenomas,
on the other hand, usually had elevated cystic fluid CEA
and CA 19–9 levels. However, another study indicated
that cystic fluid CEA and CA 19–9 levels were not use-
ful in differentiating biliary cystadenoma from simple
cysts [12]. They reported that both hepatic simple cysts
and biliary cystadenoma could have elevated cystic fluid
CEA and CA 19–9 levels. Our study did not compare
the difference between those hepatic simple cysts and
intrahepatic biliary cystadenomas. Nevertheless, among
patients with available data, we found that serum and
cystic fluid CA 19–9 levels were invariably elevated in
the intrahepatic biliary cystadenomas. In addition, cystic
fluid CA 19–9 level was significantly higher than that
in serum. These findings could be explained by part
the biliary origin of intrahepatic cystadenomas. As a
result, we suggest preoperative serum and cystic fluid
CA 19–9 determination to exclude intrahepatic biliary
cystadenomas.
Since there are neither sensitive nor specific clinical or
laboratory findings suggestive of intrahepatic biliary
cystadenomas, preoperative imaging studies are thus in-
dispensable for the evaluation of patients with hepatic
cystic mass. In the current study, every patient received
either contrast-enhanced CT or MRI for preoperative
evaluation. Among other features, loculations and in-
ternal septations were the two most common radiologic
characteristics in patients with intrahepatic biliary cysta-
denoma, with 87 % and 56 % of patients having these
features, respectively. Our finding was in accordance
with previous reports, in which septations and/or septal
thickening were the common radiologic features in
intrahepatic biliary cystadenomas [1, 12]. Therefore, pre-
operative contrast-enhanced radiologic study, including
CT or MRI, should be carried out and intrahepatic bil-
iary cystadenomas should be highly suspected if locula-
tions and/or internal septations are demonstrated. It is
noteworthy, however, that these radiologic features are
not specific for intrahepatic biliary cystadenomas and
the definitive diagnosis should be based on final patho-
logic finding.
Preoperative pathologic diagnosis remains difficult for
intrahepatic biliary cystadenomas. In our series, 6 pa-
tients received preoperative percutaneous aspiration cy-
tology or biopsy. The interpretation did not give any
specific diagnosis. The reason for these false negative re-
sults may be attributed to inadequate tissue sampling
upon percutaneous biopsy/aspiration since intrahepatic
biliary cystadenomas usually have rather thin walls, as
demonstrated by our study in which only 25 % of biliary
cystadenomas had thickened wall/mural nodules. As a
result, we do not suggest routine preoperative
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aspiration/biopsy only if the cystic neoplasm has appar-
ent wall thickening or mural nodules and the biopsy is
carried out by experienced hands.
The treatment of intrahepatic biliary cystadenomas re-
mains controversial among literatures. Most authors
suggested complete surgical removal by either liver re-
section or enucleation to prevent recurrence or potential
malignant transformation [1, 5, 6, 11, 15, 17, 19]. Never-
theless, there have been other authors indicating that
marsupialization of the hepatic cysts could result in opti-
mal outcome without tumor recurrence [16]. In our
study, none of the 11 patients who received radical re-
section developed recurrence postoperatively, while
more than 60 % of patients who underwent liver-
preserving surgery developed postoperative recurrence.
Given the possibility of malignant transformation, we
suggest radical resection by either hepatic resection or
enucleation for suspected intrahepatic biliary cystadeno-
mas. The emergence of laparoscopic techniques in re-
cent decades renders the surgeons more options
regarding hepatic surgery and should also be considered.
Since most patients with intrahepatic biliary cystadeno-
mas are non-cirrhotic in the absence of viral hepatitis,
hepatic resection should be relatively safe, provided that
adequate future liver remnant is reserved. On the other
hand, in the cases of hepatic viral infection and/or cir-
rhosis, liver functions, particularly indocyanine green
15 min retention test (ICG-15), should be taken into
consideration before performing radical hepatic resec-
tion. The result after well-planned radical hepatic resec-
tion is usually good and patients can achieve satisfactory
long-term outcome.
As for intrahepatic biliary cystadenocarcinoma, a re-
cent study has shown that older age, male gender, and
shorter symptom duration were the major differences
from biliary cystadenoma [18]. The current study, al-
though with limited cases, agreed to that publication. In
addition, a septated cystic mass with a solid mural com-
ponent on image study should also raise our suspicion
of this diagnosis [9]. As for treatment, we suggest radical
resection with negative resection margin for suspected
intrahepatic biliary cystadenocarcinomas. This approach
has been the only potentially curative treatment pro-
posed by most other authors [1, 17]. Reported survival
rates for intrahepatic biliary cystadenocarcinomas ranged
from 25 % to 100 % at 5 years [1]. Despite its poor prog-
nosis, our patients survived for at least 2 years after the
operations.
Conclusion
Intrahepatic biliary mucinous cystic neoplasms are rare
and preoperative diagnosis is difficult. High serum and
cystic fluid CA 19–9 levels, together with loculated and
septated cystic lesions on radiologic exams, should raise
clinical suspicion of biliary cystadenoma and cystadeno-
carcinoma. Biliary cystadenomas occur predominantly,
but not exclusively, in females. Preoperative tissue diag-
nosis, either by percutaneous aspiration or biopsy, may
be falsely negative and thus is not routinely recom-
mended. Percutaneous aspiration, surgical fenestration,
and marsupialization are inadequate treatments and in-
variably result in persistence or recurrence of disease.
The standard treatment of choice is complete tumor ex-
cision, either by tumor enucleation or hepatic resection.
Patients can achieve satisfactory long-term results once
biliary cystic neoplasm is completely resected.
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